Showing results (241-250 of 969) with videos related to
Sort By:
Pageof 97
Cancer|July 17, 2019
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemiaKoji Sasaki, Hagop M Kantarjian, Tapan Kadia, et al.Blood|April 7, 2022
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemiaMehrnoosh Tashakori, Tapan Kadia, Sanam Loghavi, et al.Journal of Hematology & Oncology|November 16, 2024
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosisSamuel Urrutia, Hagop M Kantarjian, Farhad Ravandi-Kashani, et al.Clinical Lymphoma, Myeloma & Leukemia|September 10, 2023
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End ResultsKoji Sasaki, Kiyomi Morita, Hagop Kantarjian, et al.Blood Advances|November 19, 2020
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemiaNicholas J Short, Guillermo Montalban-Bravo, Hyunsoo Hwang, et al.Leukemia & Lymphoma|August 12, 2021
Clinical and molecular characterization of myeloid sarcoma without medullary leukemiaHussein A Abbas, Patrick K Reville, Alexis Geppner, et al.Acta Haematologica|May 12, 2020
Treating Leukemia in the Time of COVID-19Shilpa Paul, Caitlin R Rausch, Nitin Jain, et al.The Lancet. Haematology|March 28, 2024
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trialAlexandre Bazinet, Hagop Kantarjian, Alex Bataller, et al.Leukemia & Lymphoma|March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletionsEitan Kugler, Enes Dasdemir, Alex Bataller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALLHagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.Pageof 97